Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 37

Sort by

Sort Order Select

Journal Articles

Thrombin-Induced Endothelial Cell Damage Is Mitigated By Human Anti-Thrombin III in a Microfluidic Device

William Wulftange, Erdem Kucukal, PhD, Yuncheng Man, Ran An, PhD, Karamoja Monchamp, Olabimpe Olayiwola, MS, Jane A. Little, MD, Nigel S. Key, MD, Umut A. Gurkan, PhD

Blood (2020) 136 (Supplement 1): 24–25.

https://doi.org/10.1182/blood-2020-141583

Published: 2020

Journal Articles

Computer Vision and Deep Learning Assisted Microchip Electrophoresis for Integrated Anemia and Sickle Cell Disease Screening

Ran An, PhD, Yuncheng Man, Shamreen Iram, Erdem Kucukal, PhD, Muhammad Noman Hasan, PhD, Ambar Solis-Fuentes, Allison Bode, Ailis Hill, Kevin Cheng, Yuning Huang, Sanjay Ahuja, MD, Jane A. Little, MD, Michael Hinczewski, PhD, Umut A. Gurkan, PhD

Blood (2020) 136 (Supplement 1): 46–47.

https://doi.org/10.1182/blood-2020-142548

Published: 2020

Journal Articles

Exercise Induced Changes of Vital Signs in Adults with Sickle Cell Disease

Solomon Johnson, MS, Victor R. Gordeuk, MD, Roberto Machado, MD, J Simon R Gibbs, Mariana Hildesheim, MS, Jane A. Little, MD, Gregory J Kato, MD, Mark T Gladwin, MD, Seyed Mehdi Nouraie, PhD MD

Blood (2020) 136 (Supplement 1): 59–60.

https://doi.org/10.1182/blood-2020-136393

Published: 2020

Journal Articles

Assessment of Red Blood Cell-Mediated Microvascular Occlusion in Sickle Cell Disease By a Novel Electrical Impedance-Based Microfluidic Device

Yuncheng Man, Debnath Maji, PhD, Ran An, PhD, Sanjay P Ahuja, MD, Jane A. Little, MD, Pedram Mohseni, PhD, Michael A Suster, PhD, Umut A. Gurkan, PhD

Blood (2020) 136 (Supplement 1): 10.

https://doi.org/10.1182/blood-2020-138876

Published: 2020

Journal Articles

Contribution of Red Blood Cell Derived Extracellular Vesicles to Sickle Red Blood Cell Adhesion Discerned Using an Endothelialized Microfluidic Assay

Ran An, PhD, Yuncheng Man, Erdem Kucukal, PhD, Kevin Cheng, William Wulftange, Jane A. Little, MD, Umut A. Gurkan, PhD

Blood (2020) 136 (Supplement 1): 13–14.

https://doi.org/10.1182/blood-2020-142176

Published: 2020

Journal Articles

The Grndad Registry: Contemporary Natural History Data and an Analysis of Real-World Patterns of Use and Limitations of Disease Modifying Therapy in Adults with SCD

Alexandra Boye-Doe, Elizabeth Brown, Charu Puri-Sharma, MS, Anjulika Chawla, MD, Joshua J Field, Lynne D. Neumayr, MD, Susan Padrino, MD, Payal Desai, MD, Deepa Manwani, MD, Sophie M. Lanzkron, MD MHS, Jane A. Little, MD

Blood (2020) 136 (Supplement 1): 34–36.

https://doi.org/10.1182/blood-2020-138895

Published: 2020

Journal Articles

International Multi-Site Clinical Validation of Point-of-Care Microchip Electrophoresis Test for Hemoglobin Variant Identification

Blood (2019) 134 (Supplement_1): 3373.

https://doi.org/10.1182/blood-2019-129336

Published: 2019

Journal Articles

Chronic Kidney Disease Is Under-Screened in SCD and Mild Albuminuria Is Associated with a Drop in Hemoglobin: A Report from the Grndad Sickle Cell Registry

Elizabeth Williams, BA, Elizabeth Brown, Deepa Manwani, MD, Payal Desai, MD, Joshua J. Field, MD, Lynne D. Neumayr, Susan Padrino, MD, E. Leila Jerome Clay, MD MCTS, FAAP, Ze Cong, PhD, Irene Agodoa, MD, Carolyn Hoppe, MD, Sophie M. Lanzkron, MD, Jane A. Little, MD

Blood (2019) 134 (Supplement_1): 2284.

https://doi.org/10.1182/blood-2019-124933

Published: 2019

Journal Articles

Manifestations of Reduced Kidney Function Occur at a Higher Estimated Glomerular Filtration Rate in Sickle Cell Anemia

Santosh L. Saraf, MD, Vimal K. Derebail, MD, Xu Zhang, PhD, Mark T Gladwin, MD, Victor R Gordeuk, MD, Jane A. Little, MD

Blood (2019) 134 (Supplement_1): 2268.

https://doi.org/10.1182/blood-2019-124737

Published: 2019

Journal Articles

Venous Thromboembolism (VTE) in Sickle Cell Disease (SCD) Is Associated with Neutrophilia

Jahnavi Gollamudi, MD, Shashank Sarvepalli, MD, Tara Alin, APRN-CNP, Animesh Vadaparti, M.Binf, Jane A. Little, MD, Lalitha V. Nayak, MD

Blood (2019) 134 (Supplement_1): 791.

https://doi.org/10.1182/blood-2019-128855

Published: 2019

Journal Articles

Prevalence and Monitoring of Diabetes Among Adults with Sickle Cell Disease: A Single Institution Experience

Ashley McLean, MS2, Laura Young, MD PhD, Marcella H. Boynton, PhD, Samuel Wilson, MD, Jane A. Little, MD, Marcus A. Carden, MD

Blood (2019) 134 (Supplement_1): 4832.

https://doi.org/10.1182/blood-2019-128843

Published: 2019

Journal Articles

Pilot Use of a Novel DNA Methytransferase -1 (DNMT1) Flow Cytometric Pharmacodynamic Assay to Evaluate Response to Low-Dose Azacitidine Therapy for Acute Myeloid Leukemia or Myelodysplastic Syndrome Relapse after Allogeneic Hematopoietic Cell Transplantation

Najla H El Jurdi, MD, Masumi Ueda, MD MA, BA, Philip Woost, PhD, Hillard M Lazarus, MD, Paolo Caimi, MD, Brenda W. Cooper, MD, Richard Creger, PhD, Jane A. Little, MD, Linda Baer, MSN, NP-C, AOCNP, Lauren Brister, MSN, NP-C, AOCNP, Ehsan Malek, MD, Leland Metheny, MD, Folashade Otegbeye, MBBChir, MPH, Ben K. Tomlinson, MD, Basem M. William, MRCP,MD, James Jacobberger, PhD, Marcos De Lima, MD

Blood (2017) 130 (Supplement 1): 5503.

https://doi.org/10.1182/blood.V130.Suppl_1.5503.5503

Published: 2017

Journal Articles

A Prospective Multi-Centered Registry Is Feasible in Sickle Cell Disease: Globin Regional Network for Data and Discovery (GRNDaD)

Matthew Sears, Caroline Ewing, Sophie Lanzkron, MD, Joshua J. Field, MD, Carolyn C Hoppe, MD, Jane A. Little, MD

Blood (2017) 130 (Supplement 1): 3375.

https://doi.org/10.1182/blood.V130.Suppl_1.3375.3375

Published: 2017

Journal Articles

Hemechip: An Automated Portable Microchip Electrophoresis Platform for Point-of-Care Sickle Cell Disease Screening

Muhammad Noman Hasan, MS, Arwa Fraiwan, PhD, Jane A. Little, MD, Umut A. Gurkan, PhD

Blood (2017) 130 (Supplement 1): 3519.

https://doi.org/10.1182/blood.V130.Suppl_1.3519.3519

Published: 2017

Journal Articles

Longitudinal Monitoring of RBC Adhesion in Patients with SCD Is Heterogeneous and Clinically informative

Erdem Kucukal, MS, Erina Quinn, Charlotte Yuan, Constance Fung, Jane A. Little, MD, Umut A. Gurkan, PhD

Blood (2017) 130 (Supplement 1): 953.

https://doi.org/10.1182/blood.V130.Suppl_1.953.953

Published: 2017

Journal Articles

Adhesion of Sickle RBCs to Heme-Activated Endothelial Cells Correlates with Patient Clinical Phenotypes

Erdem Kucukal, MS, Anton Ilich, MD, Nigel S. Key, MBChB, FRCP, Jane A. Little, MD, Umut A. Gurkan, PhD

Blood (2017) 130 (Supplement 1): 959.

https://doi.org/10.1182/blood.V130.Suppl_1.959.959

Published: 2017

Journal Articles

Patient-Specific Adhesion of Sickle Red Blood Cells in Shear-Gradient Microscale Flow

Erdem Kucukal, MS, Jane A. Little, MD, Umut A. Gurkan, PhD

Blood (2017) 130 (Supplement 1): 964.

https://doi.org/10.1182/blood.V130.Suppl_1.964.964

Published: 2017

Journal Articles

A Phase 1 Trial of MEC (Mitoxantrone, Etoposide, Cytarabine) in Combination with Ixazomib (MLN9708) for Relapsed/ Refractory Acute Myeloid Leukemia (AML): Final Results

Blood (2017) 130 (Supplement 1): 150.

https://doi.org/10.1182/blood.V130.Suppl_1.150.150

Published: 2017

Journal Articles

Men with Sickle Cell Disease Show Significant Concerns over Safety While Being Treated for Vaso-Occlusive Crises: Preliminary Observations from the Escaped Trial

Blood (2017) 130 (Supplement 1): 129.

https://doi.org/10.1182/blood.V130.Suppl_1.129.129

Published: 2017

Journal Articles

A Phase II Study of Midostaurin and 5-Azacitidine for Elderly Patients with Acute Myeloid Leukemia

Molly M Gallogly, MDPhD, Ben K. Tomlinson, MD, Pam Bunner, MT, CCRC, Paolo Caimi, MD, Michael Craig, MD, Marcos de Lima, MD, Stanton L. Gerson, MD, Donna Kane, RN, MSN, Hillard M Lazarus, MD, Mark J. Levis, MD, Ehsan Malek, MD, Jane A. Little, MD, Crystal Street, MT, CCRC, Willem J. van Heeckeren, MD PhD, William Tse, MD, Brenda W. Cooper, MD

Blood (2017) 130 (Supplement 1): 1332.

https://doi.org/10.1182/blood.V130.Suppl_1.1332.1332

Published: 2017

NARROW

Thrombin-Induced Endothelial Cell Damage Is Mitigated By Human Anti-Thrombin III in a Microfluidic Device

Computer Vision and Deep Learning Assisted Microchip Electrophoresis for Integrated Anemia and Sickle Cell Disease Screening

Exercise Induced Changes of Vital Signs in Adults with Sickle Cell Disease

Assessment of Red Blood Cell-Mediated Microvascular Occlusion in Sickle Cell Disease By a Novel Electrical Impedance-Based Microfluidic Device

Contribution of Red Blood Cell Derived Extracellular Vesicles to Sickle Red Blood Cell Adhesion Discerned Using an Endothelialized Microfluidic Assay

The Grndad Registry: Contemporary Natural History Data and an Analysis of Real-World Patterns of Use and Limitations of Disease Modifying Therapy in Adults with SCD

International Multi-Site Clinical Validation of Point-of-Care Microchip Electrophoresis Test for Hemoglobin Variant Identification

Chronic Kidney Disease Is Under-Screened in SCD and Mild Albuminuria Is Associated with a Drop in Hemoglobin: A Report from the Grndad Sickle Cell Registry

Manifestations of Reduced Kidney Function Occur at a Higher Estimated Glomerular Filtration Rate in Sickle Cell Anemia

Venous Thromboembolism (VTE) in Sickle Cell Disease (SCD) Is Associated with Neutrophilia

Prevalence and Monitoring of Diabetes Among Adults with Sickle Cell Disease: A Single Institution Experience

Pilot Use of a Novel DNA Methytransferase -1 (DNMT1) Flow Cytometric Pharmacodynamic Assay to Evaluate Response to Low-Dose Azacitidine Therapy for Acute Myeloid Leukemia or Myelodysplastic Syndrome Relapse after Allogeneic Hematopoietic Cell Transplantation

A Prospective Multi-Centered Registry Is Feasible in Sickle Cell Disease: Globin Regional Network for Data and Discovery (GRNDaD)

Hemechip: An Automated Portable Microchip Electrophoresis Platform for Point-of-Care Sickle Cell Disease Screening

Longitudinal Monitoring of RBC Adhesion in Patients with SCD Is Heterogeneous and Clinically informative

Adhesion of Sickle RBCs to Heme-Activated Endothelial Cells Correlates with Patient Clinical Phenotypes

Patient-Specific Adhesion of Sickle Red Blood Cells in Shear-Gradient Microscale Flow

A Phase 1 Trial of MEC (Mitoxantrone, Etoposide, Cytarabine) in Combination with Ixazomib (MLN9708) for Relapsed/ Refractory Acute Myeloid Leukemia (AML): Final Results

Men with Sickle Cell Disease Show Significant Concerns over Safety While Being Treated for Vaso-Occlusive Crises: Preliminary Observations from the Escaped Trial

A Phase II Study of Midostaurin and 5-Azacitidine for Elderly Patients with Acute Myeloid Leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only